Follow
Rob van Binnendijk
Rob van Binnendijk
Other namesRobert S van Binnendijk, RS van Binnendijk, Rob S van Binnendijk
Unknown affiliation
Verified email at rivm.nl
Title
Cited by
Cited by
Year
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
CH GeurtsvanKessel, NMA Okba, Z Igloi, S Bogers, CWE Embregts, ...
Nature communications 11 (1), 3436, 2020
3692020
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ...
The Lancet Oncology 22 (12), 1681-1691, 2021
1472021
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a …
JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ...
Transplantation 106 (4), 821-834, 2022
1412022
Rubella outbreak in the Netherlands, 2004–2005: high burden of congenital infection and spread to Canada
S Hahné, J Macey, R van Binnendijk, R Kohl, S Dolman, Y van der Veen, ...
The Pediatric infectious disease journal 28 (9), 795-800, 2009
1202009
Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014
SJM Hahné, LM Nic Lochlainn, ND van Burgel, J Kerkhof, J Sane, KB Yap, ...
The Journal of infectious diseases 214 (12), 1980-1986, 2016
1192016
Measles outbreak in a community with very low vaccine coverage, the Netherlands.
S van den Hof, CM Meffre, MA Conyn-van Spaendonck, F Woonink, ...
Emerging infectious diseases 7 (3 Suppl), 593, 2001
1142001
Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and …
P de Vries, RS Van Binnendijk, P van der Marel, AL van Wezel, ...
Journal of general virology 69 (3), 549-559, 1988
1141988
High genetic diversity of measles virus, world health organization european region, 2005–2006
JR Kremer, KE Brown, L Jin, S Santibanez, SV Shulga, Y Aboudy, ...
Emerging Infectious Diseases 14 (1), 107, 2008
1132008
Epidemic of mumps among vaccinated persons, The Netherlands, 2009–2012
J Sane, S Gouma, M Koopmans, H de Melker, C Swaan, R van Binnendijk, ...
Emerging infectious diseases 20 (4), 643, 2014
1062014
Profiling of humoral immune responses to influenza viruses by using protein microarray
M Koopmans, E de Bruin, GJ Godeke, I Friesema, R Van Gageldonk, ...
Clinical Microbiology and Infection 18 (8), 797-807, 2012
1022012
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
ERA Vos, G den Hartog, RM Schepp, P Kaaijk, J van Vliet, K Helm, ...
J epidemiol community health 75 (6), 489-495, 2021
992021
Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
T Woudenberg, RS van Binnendijk, EAM Sanders, J Wallinga, ...
Eurosurveillance 22 (3), 30443, 2017
892017
Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010
J Whelan, R Van Binnendijk, K Greenland, E Fanoy, M Khargi, K Yap, ...
Eurosurveillance 15 (17), 19554, 2010
892010
Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010
K Greenland, J Whelan, E Fanoy, M Borgert, K Hulshof, KB Yap, C Swaan, ...
Vaccine 30 (31), 4676-4680, 2012
852012
Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
RD de Vries, NJ Nieuwkoop, M Pronk, E de Bruin, G Leroux-Roels, ...
Vaccine 35 (2), 238-247, 2017
632017
Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
LMN Lochlainn, B de Gier, N van der Maas, PM Strebel, T Goodman, ...
The Lancet Infectious Diseases 19 (11), 1235-1245, 2019
572019
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19
S Haggenburg, Q Hofsink, BI Lissenberg-Witte, AEC Broers, ...
JAMA oncology 8 (10), 1477-1483, 2022
562022
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
S Haggenburg, BI Lissenberg-Witte, RS Van BInnendijk, G Den Hartog, ...
Blood advances 6 (5), 1537-1546, 2022
522022
Polio and measles down the drain: environmental enterovirus surveillance in the Netherlands, 2005 to 2015
KSM Benschop, HG van der Avoort, E Jusic, H Vennema, ...
Applied and environmental microbiology 83 (13), e00558-17, 2017
512017
Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
CH GeurtsvanKessel, NMA Okba, Z Igloi, CWE Embregts, BM Laksono, ...
MedRxiv, 2020.04. 23.20077156, 2020
502020
The system can't perform the operation now. Try again later.
Articles 1–20